Overview
-$82.1KNet income, fiscal 20262
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-05-31 | 2025-05-31 |
|---|---|---|
| General and administrative | $82.1K | $52.7K |
| Total operating expenses | $82.1K | $52.7K |
| Loss from operations | -$82.1K | -$52.7K |
| Loss before income taxes | -$82.1K | -$52.7K |
| Net loss | -$82.1K | -$52.7K |
| Basic (loss) per common share | $0.00 | $0.00 |
| Diluted earnings per common share | $0.00 | $0.00 |
| Weighted-weighted average number of shares outstanding Basic | 120.2M shares | 28.4M shares |
| Weighted-weighted average number of shares outstanding Diluted | 120.2M shares | 28.4M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-11-30 |
|---|---|---|---|---|
| Accounts payable and accrued liabilities | $12.1K | $34.1K | ||
| Notes payable related parties | $122.8K | $18.6K | $45.1K | |
| Total current liabilities | $134.9K | $52.7K | ||
| Common stock, $0.001 par value, 7,000,000,000 shares authorized, 568,735, and 28,436,782 shares issued and outstanding respectively, as of May 31, 2026 and May 31, 2025 | $568.7K | $28.4K | ||
| Additional paid-in capital | $13.6M | $14.2M | ||
| Accumulated deficit | -$14.3M | -$14.3M | ||
| Total Stockholders deficit | -$134.9K | -$52.7K | -$45.1K | |
| Preferred stock, par value | $0.10 | $0.10 | ||
| Preferred stock, shares authorized | 0 shares | 0 shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 7.0B shares | 7.0B shares | ||
| Common stock, shares issued | 568.7K shares | 28.4M shares | ||
| Common stock, shares outstanding | 568.7K shares | 28.4M shares |
| Period ending | 2026-05-31 | 2025-05-31 | 2024-05-31 | 2023-11-30 |
|---|---|---|---|---|
| Accounts payable and accrued liabilities | $12.1K | $34.1K | ||
| Notes payable related parties | $122.8K | $18.6K | $45.1K | |
| Total current liabilities | $134.9K | $52.7K | ||
| Common stock, $0.001 par value, 7,000,000,000 shares authorized, 568,735, and 28,436,782 shares issued and outstanding respectively, as of May 31, 2026 and May 31, 2025 | $568.7K | $28.4K | ||
| Additional paid-in capital | $13.6M | $14.2M | ||
| Accumulated deficit | -$14.3M | -$14.3M | ||
| Total Stockholders deficit | -$134.9K | -$52.7K | -$45.1K | |
| Preferred stock, par value | $0.10 | $0.10 | ||
| Preferred stock, shares authorized | 0 shares | 0 shares | ||
| Preferred stock, shares issued | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding | 0 shares | 0 shares | ||
| Common stock, par value | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 7.0B shares | 7.0B shares | ||
| Common stock, shares issued | 568.7K shares | 28.4M shares | ||
| Common stock, shares outstanding | 568.7K shares | 28.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.2
| Period ending | 2026-05-31 | 2025-05-31 |
|---|---|---|
| Net (loss) | -$82.1K | -$52.7K |
| Accounts payable and accrued liabilities | -$22.1K | $34.1K |
| Net cash (used in) operating activities | -$104.2K | -$18.6K |
| Notes payable related parties | $104.2K | $18.6K |
| Net cash provided by financing activities | $104.2K | $18.6K |
| Sale of Series A-1 Preferred Stock as forgiveness of notes payable-related party debt | $45.1K |
No quarter-by-quarter statement was filed.
Compare Longevity Diversified Holdings, Inc. with another company
What it owns
What Longevity Diversified Holdings, Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Investments
Former names
Timeline
Filings
22 filings to the SEC since October 2021: 4 annual reports, 10 quarterly reports, 4 major events, 4 other. The latest 20:
- Oct 15, 202610-Q EDGAR
- Sep 15, 202610-K EDGAR
- Aug 31, 2026NT 10-K EDGAR
- Jul 6, 20268-K EDGAR
- Apr 24, 202610-12G EDGAR
- Apr 20, 202610-Q EDGAR
- Apr 14, 2026NT 10-Q EDGAR
- Apr 2, 20268-K EDGAR
- Jan 12, 202610-Q EDGAR
- Oct 14, 202510-Q EDGAR
- Sep 11, 202510-K EDGAR
- Aug 28, 2025NT 10-K EDGAR
- Aug 7, 20258-K EDGAR
- Aug 4, 202510-Q EDGAR
- Aug 4, 202510-Q EDGAR
- Aug 4, 202510-Q EDGAR
- Jun 6, 202510-K EDGAR
- Jul 15, 20248-K EDGAR
- Mar 25, 202410-Q EDGAR
- Mar 21, 202410-Q EDGAR
The 22 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
SEC filer profile
How Longevity Diversified Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARLongevity Diversified Holdings, Inc.1
- CIK0000787496
- Employer ID (EIN)87-043574114
- Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company14
- Incorporated inNevada14
- Fiscal year endsMay 311
- Industry code (SIC)6770 Blank Checks1
- SEC reviewing officeOffice of Real Estate & Construction, Division of Corporation Finance1
- Business address2855 University Dr, Ste 200, Coral Springs, FL 330651
- Mailing address2855 University Drive, Suite 200, Coral Springs, FL 330651
- Phone95457572961
- Shares outstanding568,735,798 as of Oct 15, 20268
- Public float$0 as of Nov 30, 20252
- AuditorBeckles & Co, West Palm Beach, FL PCAOB ID 711614
- On EDGAR sinceAug 30, 19961
- Filings61 in all: 10-Q (12), 8-K (11), 10-K (5), 10QSB (5), 3 (4), NT 10-K (4), 10KSB (3), NT 10-Q (3)1
All 20 form types
8-K/A (2), SC 13D (2), 10-12G (1), 10-K/A (1), 10KSB/A (1), 4 (1), 5/A (1), DEF 14A (1), NTN 10K (1), NTN 10Q (1), S-8 POS (1), SC 13D/A (1)
- Latest filingsAnnual report (10-K) Sep 15, 2026
Quarterly report (10-Q) Oct 15, 2026
Proxy statement (DEF 14A) Nov 14, 2000
Latest 8-K (8-K) Jul 6, 2026
Risk factors and legal proceedings
The risks Longevity Diversified Holdings, Inc. names in Item 1A of its 10-K filed Sep 15, 2026: 27 risks under these headings, as written.14
- Risks Relating to Our Business and Financial Condition
- We currently have no operations, and investors therefore have no basis for evaluating the Company’s future prospects.
- We may face difficulties or delays in our search for a business combination and may not have access to sufficient capital to consummate it.
- Investors will likely lose their investment if we are not successful in acquiring a new business and generating material revenues.
- We may not become profitable if we cannot manage our growth effectively.
- Because we have limited capital, we may need to raise additional capital in the future by issuing debt or equity securities, the terms of which may dilute our current investors and/or reduce or limit their liquidation or other rights.
- We may be unable to obtain necessary financing if and when required.
- Because we are still developing our business plan, we do not have any agreement for a business combination.
- Risks Related to a Potential Business Acquisition
- We may encounter difficulty locating and consummating a business combination, including as a result of the competitive disadvantages we have.
- We may expend significant time and capital on a prospective business combination that is not ultimately consummated.
- Conflicts of interest may arise between us and our shareholders, directors, or management, which may have a negative impact on our ability to consummate a business combination or favorable terms or generate revenue.
The other 17 risks
- We may engage in a business combination that causes tax consequences to us and our shareholders.
- Our shareholders will unlikely to be afforded any opportunity to evaluate or approve a business combination.
- Because our search for a business combination is not presently limited to a particular industry, sector or any specific target businesses, prospective investors will be unable to evaluate the merits or risks of any particular target business’s operations until such time as they are identified and disclosed.
- Past performance by our management and their affiliates may not be indicative of the future performance of an investment in us.
- We may seek business combination opportunities in industries or sectors that are outside of our management’s area of expertise.
- We may attempt to complete a business combination with a private target company about which little information is available, and such target entity may not generate revenue as expected or otherwise by compatibility with us as expected.
- Our ability to assess the management of a prospective target business may be limited and, as a result, we may acquire a target business whose management does not have the skills, qualifications, or abilities to enable a seamless transition, which could, in turn, negatively impact our results of operations.
- Any business we acquire will likely lack diversity of operations or geographical reach, and in such case, we will be subject to risks associated with dependence on a single industry or region.
- Changes in laws or regulations, or failure to comply with the laws and regulations applicable to us, may adversely affect our business, our ability to negotiate and complete a business combination, and the results of our operations.
- Because we are considered a “shell company” under applicable securities rules, investors may be unable to rely on the resale exemption provided by Rule 144 of the Securities Act. As a result, investors may be unable to resell their shares and could lose their entire investment. We are also subject to additional disclosure requirements if we acquire or dispose of significant assets during our business. We will incur additional costs in meeting these requirements, adversely impacting on our financial performance and, therefore, the value of your investment.
- Rule 144 safe harbor does not apply to the resale of shares issued by us unless and until we have ceased to be a shell company and have satisfied the requirements of Rule 144(i)(1)(2).
- Because we are a “shell company,” the holders of our restricted securities will not be able to sell their securities in reliance on Rule 144, and we cannot file registration statements under Section 5 of the Securities Act using a Form S-8 until we cease being a “shell company.”
- Risks Related to Our Common Stock
- Due to factors beyond our control, our stock price may be volatile.
- Because trading in our Common Stock is so limited, investors who purchase our Common Stock may depress the market if they sell Common Stock.
- The market price of our Common Stock may decline if a substantial number of shares are sold at once or in large blocks.
- Future issuance of our Common Stock could dilute the interests of our existing shareholders, particularly in connection with an acquisition and any resulting financing.
- Due to recent changes to Rule 15c2-11 under the Securities Exchange Act of 1934, our Common Stock may become subject to limitations or reductions on stock price, liquidity, or volume.
Legal proceedings
We are not currently involved in any legal proceedings and are unaware of any pending or potential legal actions.
The opening of Item 3, Legal Proceedings.14
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11SEC EDGAROther events
- 12SEC EDGARExecutive or director change
- 13
- 14